Resultados financieros en millones de dólares estadounidenses. El ejercicio fiscal es febrero - enero.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Ingresos
280,694
275,250
260,295
231,981
215,824
191,909
Crecimiento de los Ingresos (YoY)
3%
6%
12%
7%
12%
3%
Costo de los ingresos
251,639
244,758
229,276
201,503
187,332
164,871
Utilidad bruta
29,055
30,492
31,018
30,477
28,491
27,039
Venta, General y Administración
18,688
17,932
19,279
18,914
17,751
16,696
Investigación y Desarrollo
2,293
2,162
1,998
1,940
1,827
1,540
Gastos de Operación
21,584
21,255
22,157
22,162
20,690
19,299
Otras Ingresos (Gastos) No Operativos
-134
-94
-600
-168
-53
26
Ingreso antes de impuestos
9,673
8,020
7,054
8,808
8,143
7,175
Gasto por Impuesto a la Renta
2,840
2,149
1,887
1,816
1,869
1,570
Ingreso Neto
5,645
4,552
3,767
5,617
5,093
4,496
Crecimiento de la Utilidad Neta
40%
21%
-33%
10%
13%
10%
Acciones en Circulación (Diluidas)
3,677.33
3,704.06
3,701.29
3,482.73
2,845.51
2,846
Cambio de Acciones (YoY)
-1%
0%
6%
22%
0%
0%
EPS (Diluido)
1.52
1.22
1.01
1.61
1.79
1.58
Crecimiento de EPS
40%
21%
-37%
-10%
13%
10%
Flujo de efectivo libre
3,216
3,426
2,260
2,058
942
3,834
Flujo de efectivo libre por acción
--
--
--
--
--
--
Margen bruto
10.35%
11.07%
11.91%
13.13%
13.2%
14.08%
Margen de operación
2.66%
3.35%
3.4%
3.58%
3.61%
4.03%
Margen de beneficio
2.01%
1.65%
1.44%
2.42%
2.35%
2.34%
Margen de flujo de caja libre
1.14%
1.24%
0.86%
0.88%
0.43%
1.99%
EBITDA
--
10,944
10,417
9,872
9,334
9,311
Margen de EBITDA
--
3.97%
4%
4.25%
4.32%
4.85%
D&A para EBITDA
--
1,707
1,557
1,557
1,534
1,571
EBIT
7,471
9,237
8,860
8,315
7,800
7,740
Margen de EBIT
2.66%
3.35%
3.4%
3.58%
3.61%
4.03%
Tasa de Impuesto Efectiva
29.36%
26.79%
26.75%
20.61%
22.95%
21.88%
Estadísticas clave
Cierre Anterior
$1.46
Precio de apertura
$1.46
Rango del día
$1.46 - $1.46
Rango de 52 semanas
$1.46 - $15.7
Volumen
100
Volumen promedio
1
EPS (TTM)
0.21
Rendimiento de dividendos
--
Cap. de mercado
$5.4B
¿Qué es SHPMF?
Shanghai Pharmaceuticals Holding Co Ltd is a CN-based company operating in Health Care Providers & Services industry. The company is headquartered in Shanghai, Shanghai and currently employs 49,402 full-time employees. Shanghai Pharmaceuticals Holding Co Ltd is a China-based company principally engaged in pharmaceutical industry, distribution and retail business. The firm's products include innovative drugs, chemical drugs, traditional Chinese medicines and rare disease drugs. The firm's products are mainly used in the cardiovascular system, digestive tract and metabolism, systemic anti-infection, central nervous system, anti-tumor and immunomodulators, musculoskeletal system and respiratory system. In addition, the Company also provides medical logistics and warehousing services. The firm distributes its products both in the domestic market and to overseas markets.